TrueTear Intranasal Tear Neurostimulator

Intranasal Electrostimulation Device For Dry Eye Symptoms

Allergan

The following data is part of a De Novo classification by Allergan with the FDA for Truetear Intranasal Tear Neurostimulator.

Pre-market Notification Details

DeNovo IDDEN170086
Device Name:TrueTear Intranasal Tear Neurostimulator
ClassificationIntranasal Electrostimulation Device For Dry Eye Symptoms
Applicant Allergan 2525 Dupont Drive Irvine,  CA  92612
ContactNooshin Azizi
Product CodeQBR  
CFR Regulation Number886.5310 [🔎]
DecisionGranted (DENG)
510(k) Premarket NotificationDevice Classification Under Section 513(f)(2)(de Novo) // Quick Links: Skip To Main Page Content Skip To Search Skip To Topics Menu Skip To Common Lin
Review Advisory BoardOphthalmic
Classification AdvisoryOphthalmic
TypeDirect
Date Received2017-10-23
Decision Date2018-05-17
FDA ReviewDecision Summary
Reclassification Order:Reclassification Order

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.